69 related articles for article (PubMed ID: 26112157)
21. Hydroxychavicol, a novel betel leaf component, inhibits platelet aggregation by suppression of cyclooxygenase, thromboxane production and calcium mobilization.
Chang MC; Uang BJ; Tsai CY; Wu HL; Lin BR; Lee CS; Chen YJ; Chang CH; Tsai YL; Kao CJ; Jeng JH
Br J Pharmacol; 2007 Sep; 152(1):73-82. PubMed ID: 17641677
[TBL] [Abstract][Full Text] [Related]
22. Effect of some cyclooxygenase inhibitors on the increase in guanosine 3':5'-cyclic monophosphate induced by NO-donors in human whole platelets.
Failli P; Cecchi E; Tosti-Guerra C; Mugelli A; Laffi G; Zilletti L; Giotti A
Br J Pharmacol; 1998 Apr; 123(7):1457-63. PubMed ID: 9579743
[TBL] [Abstract][Full Text] [Related]
23. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
[TBL] [Abstract][Full Text] [Related]
24. Bidirectional effects of dexmedetomidine on human platelet functions in vitro.
Kawamoto S; Hirakata H; Sugita N; Fukuda K
Eur J Pharmacol; 2015 Nov; 766():122-8. PubMed ID: 26435028
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of COX-1/COX-2 selectivity and potency of a new class of COX-2 inhibitors.
Gierse J; Nickols M; Leahy K; Warner J; Zhang Y; Cortes-Burgos L; Carter J; Seibert K; Masferrer J
Eur J Pharmacol; 2008 Jun; 588(1):93-8. PubMed ID: 18457826
[TBL] [Abstract][Full Text] [Related]
26. Paracrine up-regulation of monocyte cyclooxygenase-2 by platelets: role of transforming growth factor-beta1.
Eligini S; Barbieri SS; Arenaz I; Tremoli E; Colli S
Cardiovasc Res; 2007 May; 74(2):270-8. PubMed ID: 17250815
[TBL] [Abstract][Full Text] [Related]
27. Comparison of the cyclooxygenase-1 inhibitory properties of nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors, using sensitive microsomal and platelet assays.
Riendeau D; Charleson S; Cromlish W; Mancini JA; Wong E; Guay J
Can J Physiol Pharmacol; 1997 Sep; 75(9):1088-95. PubMed ID: 9365818
[TBL] [Abstract][Full Text] [Related]
28. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
[TBL] [Abstract][Full Text] [Related]
29. The induction of cyclooxygenase-2 in IL-1beta-treated endothelial cells is inhibited by prostaglandin E2 through cAMP.
Akarasereenont P; Techatrisak K; Chotewuttakorn S; Thaworn A
Mediators Inflamm; 1999; 8(6):287-94. PubMed ID: 10815617
[TBL] [Abstract][Full Text] [Related]
30. Contribution of cyclooxygenase-1 to thromboxane formation, platelet-vessel wall interactions and atherosclerosis in the ApoE null mouse.
McClelland S; Gawaz M; Kennerknecht E; Konrad CS; Sauer S; Schuerzinger K; Massberg S; Fitzgerald DJ; Belton O
Atherosclerosis; 2009 Jan; 202(1):84-91. PubMed ID: 18514659
[TBL] [Abstract][Full Text] [Related]
31. Comparison of the effects of carvedilol, propranolol, and verapamil on in vitro platelet function in healthy volunteers.
Gasser JA; Betterridge DJ
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S29-34. PubMed ID: 1721976
[TBL] [Abstract][Full Text] [Related]
32. Investigation of cyclooxygenase and signaling pathways involved in human platelet aggregation mediated by synergistic interaction of various agonists.
Khan N; Farooq AD; Sadek B
Drug Des Devel Ther; 2015; 9():3497-506. PubMed ID: 26185418
[TBL] [Abstract][Full Text] [Related]
33. 2-Aminochromones block human platelet aggregation by inhibiting cyclic AMP-dependent phosphodiesterase leading to reduced platelet phospholipase C activity.
Benjamin CW; Lin AH; Morris J; Wishka DG; Gorman RR
J Pharmacol Exp Ther; 1993 Apr; 265(1):457-62. PubMed ID: 7682615
[TBL] [Abstract][Full Text] [Related]
34. Lack of biological relevance of platelet cyclooxygenase-2 dependent thromboxane A2 production.
Riondino S; Trifirò E; Principessa L; Mascioletti S; Di Renzo L; Gaudio C; Biasucci LM; Crea F; Pulcinelli FM
Thromb Res; 2008; 122(3):359-65. PubMed ID: 18295304
[TBL] [Abstract][Full Text] [Related]
35. Lack of influence of the COX inhibitors metamizol and diclofenac on platelet GPIIb/IIIa and P-selectin expression in vitro.
Scheinichen D; Elsner HA; Osorio R; Jüttner B; Gröschel W; Jaeger K; Piepenbrock S
BMC Anesthesiol; 2004 Apr; 4(1):4. PubMed ID: 15107131
[TBL] [Abstract][Full Text] [Related]
36. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
Fox SC; May JA; Shah A; Neubert U; Heptinstall S
Platelets; 2009 Jun; 20(4):250-9. PubMed ID: 19440925
[TBL] [Abstract][Full Text] [Related]
37. Platelet aggregation, platelet cAMP levels and thromboxane B2 synthesis in patients with diabetes mellitus.
Chen SY; Yu BJ; Liang YQ; Lin WD
Chin Med J (Engl); 1990 Apr; 103(4):312-8. PubMed ID: 2167823
[TBL] [Abstract][Full Text] [Related]
38. Antithrombotic activities of ferulic acid via intracellular cyclic nucleotide signaling.
Hong Q; Ma ZC; Huang H; Wang YG; Tan HL; Xiao CR; Liang QD; Zhang HT; Gao Y
Eur J Pharmacol; 2016 Apr; 777():1-8. PubMed ID: 26948317
[TBL] [Abstract][Full Text] [Related]
39. Houttuynia cordata water extract suppresses anaphylactic reaction and IgE-mediated allergic response by inhibiting multiple steps of FcepsilonRI signaling in mast cells.
Han EH; Park JH; Kim JY; Jeong HG
Food Chem Toxicol; 2009 Jul; 47(7):1659-66. PubMed ID: 19394399
[TBL] [Abstract][Full Text] [Related]
40. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.
Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ
Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
